Júlia Biz Willig - Concepedia

Author

Júlia Biz Willig

Universidade Federal do Rio Grande do Sul ORCID

Also Known As

J.B. Willig, Julia B. Willig, Julia B. Willig, Julia Biz Willig, Julia Willig, Júlia B. Willig, Júlia Biz Willig, Willig, Júlia

Publications

310

Citations

H-Index

Concepts

All Affiliations

Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre Universidade Franciscana Universidade Federal de Ciências da Saúde de Porto Alegre

About

Júlia Biz Willig is an author at Universidade Federal do Rio Grande do Sul specializing in medicine, radiation oncology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	123
2	Health Sciences	2	2	50
3	Natural Sciences	1	1	14
4	Public Health	1	1	13
5	Biology	1	1	14

Júlia Biz Willig

Publications

187

Citations

H-Index

Page 1

	Year	Citations
Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells Aline Beckenkamp, Júlia Biz Willig, Danielle Bertodo Santana, PLoS ONE Chemoprevention StrategyCell AdhesionImmunologyCell ProliferationCervical Carcinoma Cells	2015	39
Taste-masked nanoparticles containing Saquinavir for pediatric oral administration Katherine Krieser, Juliana Emanuelli, Renata Moschini Daudt, Materials Science and Engineering C NanomedicinePharmaceutical ScienceActive IngredientPharmacologyPharmaceutical Nanotechnology	2020	31
Design, Synthesis and Biological Evaluation of Betulinic Acid Derivatives as New Antitumor Agents for Leukemia Fernanda Waechter, Gloria N.S. da Silva, Júlia Biz Willig, Anti-Cancer Agents in Medicinal Chemistry	2017	18
Synthesis and antileukemic activity of an ursolic acid derivative: A potential co-drug in combination with imatinib Elenilson Figueiredo da Silva, Artur S. de Vargas, Júlia Biz Willig, Chemico-Biological Interactions Ursolic Acid DerivativeMedicinal ChemistryPharmaceutical ScienceMedicineAntileukemic Activity	2021	15
Heliopsis longipes S.F. Blake (Asteraceae) extract causes cell cycle arrest and induces caspase dependent apoptosis against cancer cell lines Júlia Biz Willig, Janaína Lucas de Oliveira Salomón, Débora Renz Barreto Vianna, South African Journal of Botany Chemoprevention StrategyCell DeathDependent ApoptosisOxidative StressMolecular Pharmacology	2019	14
Pooling of samples to optimize SARS-CoV-2 diagnosis by RT-qPCR: comparative analysis of two protocols Fabiana Caroline Zempulski Volpato, Daiana de Lima-Morales, Priscila Lamb Wink, European Journal of Clinical Microbiology & Infectious Diseases	2020	14
First identification of SARS-CoV-2 Lambda (C.37) variant in Southern Brazil Priscila Lamb Wink, Fabiana Caroline Zempulski Volpato, Francielle Liz Monteiro, Virus EpidemiologyViral DiagnosticsFirst IdentificationGeneticsGenetic Epidemiology	2021	13
Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil Priscila Lamb Wink, Rafaela Ramalho Guerra, Francielle Liz Monteiro, Microbiology Spectrum	2022	12
Imatinib mesylate affects extracellular ATP catabolism and expression of NTPDases in a chronic myeloid leukemia cell line Júlia Biz Willig, Débora Renz Barreto Vianna, Aline Beckenkamp, Purinergic Signalling Hematological MalignancyChromatinMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematology	2020	11
Betulinic Acid and Brosimine B Hybrid Derivatives as Potential Agents against Female Cancers Nádia Miléo Garcês de Couto, Júlia Biz Willig, Thaís Carine Ruaro, Anti-Cancer Agents in Medicinal Chemistry	2020	10

Page 1